Skip to main content

Table 1 Maternal Characteristics

From: A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion

 

Serial IV Bolus

Continuous Infusion

(n = 100)

(n = 100)

Maternal age (years) mean ± SD

29 ± 6

29 ± 6

Weight (kg) mean ± SD

91.4 ± 17.2

89.6 ± 14.8

Gestational Age (weeks) mean ± SD

35.7 ± 2.8

35.2 ± 3.3

Primigravid - N (%)

46 (46%)

24 (24%)

Multiple Pregnancy - N (%)

5 (5%)

4 (4%)

Postpartum enrollment- N (%)

0 (0%)

2 (2%)

Systolic BP (mmHg) mean ± SD

167 ± 10.9

165 ± 7.7

Diastolic BP (mmHg) mean ± SD

113 ± 7.7

113 ± 5.9

Proteinuria - N (%)

< 1+

0

0

1+

10 (10%)

17 (17%)

≥2+

90 (90%)

83 (83%)

Serum creatinine

 Initial

(μmol/L)

mean ± SD

66.3 ± 15.9

66.3 ± 15.9

range

26.5–106

26.5–106

(mg/dL)

mean ± SD

0.75 ± 0.18

0.75 ± 0.18

range

0.3–1.2

0.3–1.2

 Final

(μmol/L)

mean ± SD

73.4 ± 15.9

74.3 ± 16.8

range

44.2–133

26.5–141

(mg/dL)

mean ± SD

0.83 ± 0.18

0.84 ± 0.19

range

0.50–1.5

0.30–1.6